JAMDA
Volume 7, Issue 7 , Pages 446-447 , September 2006

Harmless Herbs? Think Again: Merits of a Complete Medication History

  • Manju T. Beier, PharmD, FASCP

      Affiliations

    • Corresponding Author InformationAddress correspondence to Manju T. Beier, PharmD, FASCP, Geriatric Consultant Resources LLC, 2001 Commonwealth Boulevard, Suite 205, Ann Arbor, MI 48105.

References 

  1. The National Center for Complementary and Alternative Medicine (NCCAM). Available at: http://nccam.nih.gov/health/supplement-safety/. Accessed May 2, 2006
  2. Ernst E . The risk-benefit profile of commonly used herbal therapies: Ginkgo, St. John’s Wort, Ginseng, Echinacea, Saw Palmetto, and Kava . Ann Intern Med . 2002;136(1):42–53
  3. Clinical Trials.gov Ginkgo biloba prevention trial in older individuals . 2006; Available at: http://www.clinicaltrials.gov/ct/show/NCT00010803?order=1. Accessed May 3
  4. Sierpina VS , Wollschlaeger B , Blumenthal M . Ginkgo biloba . Am Fam Physician . 2003;68:923–926
  5. Kupiec T , Raj V . Fatal seizures due to potential herb-drug interactions with Ginkgo biloba . J Anal Toxicol . 2005;29(7):755–758
  6. Gregory PJ . Seizure associated with Ginkgo biloba? . Ann Intern Med . 2001;134:344
  7. Granger AS . Ginkgo biloba precipitating epileptic seizures . Age Aging . 2001;30:523–525
  8. Natural Medicines Comprehensive Database. Stockton, CA: Therapeutic Research Faculty. Available at: www.naturaldatabase.com/. Accessed May 3, 2006.
  9. Wang R , Tang XC . Neuroprotective effects of huperzine A (A natural cholinesterase inhibitor for the treatment of Alzheimer’s disease) . Neurosignals . 2005;14(1-2):71–82
  10. Huperzine A in Alzheimer’s disease . 2006; Clinical Trials.gov. Available at: http://www.clinicaltrials.gov/ct/show/NCT00083590?order=8. Accessed May 3

PII: S1525-8610(06)00332-X

doi: 10.1016/j.jamda.2006.05.013

JAMDA
Volume 7, Issue 7 , Pages 446-447 , September 2006

Article Tools